Focus: Hoya Surgical Optics is a specialized manufacturer of advanced intraocular lenses (IOLs) for cataract and refractive surgery, operating as a public company with 5000+ employees across Singapore and Washington headquarters.
Profile data last refreshed 3h ago · AI intelligence enriched 2mo ago
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Best suited for specialists seeking stability in a mature, profitable surgical device company; less ideal for those seeking growth-stage R&D environment or broad pharma skill transferability.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Hoya Surgical Optics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Hoya Surgical Optics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Core intraocular lens offering for post-cataract aphakia correction.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles